This significant step brings Texray AB closer to exclusive rights for its innovative technology, which promises to advance radiation protection in the medical field by the unique Texray MindPeace Personal Protection Equipment (PPE) Device.

“This US patent reinforces Texray’s position at the forefront of protecting the Medical Professionals, reflecting the innovativeness and value of our work, and marks a major milestone for our team and stakeholders.” said CTO and co-founder, Fredrik Gellerstedt.

“I am thrilled about this exciting development and this news comes timely for entry and commercialization into the US market.” CEO and co-founder Petra Apell continues.

The newly allowed patent relates to products in Texray MindPeace collection, which is a PPE device intended to reduce cranial exposure to ionizing radiation for medical professionals during clinical interventions. MindPeace has a unique design and enhances radiation protection of the neck, face and brain with up to additional 97%, in comparison to a normal neck protector, aimed only to protect the thyroid.^{14, 15, 16, 22}

🟡

For more information about Texray’s products and this announcement, please contact Nina Offen Lantz.

About Texray AB

Texray develops the only radiation protection textile in the world, addressing the need for comfortable and functional personal protective equipment. The patented Texray material is presently utilized in products designed for healthcare professionals exposed to radiation during medical interventions. The Texray technology platform applies to various industries, including nuclear, aviation, and space.